These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 21917775)

  • 1. GFAP mutations, age at onset, and clinical subtypes in Alexander disease.
    Prust M; Wang J; Morizono H; Messing A; Brenner M; Gordon E; Hartka T; Sokohl A; Schiffmann R; Gordish-Dressman H; Albin R; Amartino H; Brockman K; Dinopoulos A; Dotti MT; Fain D; Fernandez R; Ferreira J; Fleming J; Gill D; Griebel M; Heilstedt H; Kaplan P; Lewis D; Nakagawa M; Pedersen R; Reddy A; Sawaishi Y; Schneider M; Sherr E; Takiyama Y; Wakabayashi K; Gorospe JR; Vanderver A
    Neurology; 2011 Sep; 77(13):1287-94. PubMed ID: 21917775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up study of 22 Chinese children with Alexander disease and analysis of parental origin of de novo GFAP mutations.
    Zang L; Wang J; Jiang Y; Gu Q; Gao Z; Yang Y; Xiao J; Wu Y
    J Hum Genet; 2013 Apr; 58(4):183-8. PubMed ID: 23364391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal Alexander Disease: Novel GFAP Mutation and Comparison to Previously Published Cases.
    Knuutinen O; Kousi M; Suo-Palosaari M; Moilanen JS; Tuominen H; Vainionpää L; Joensuu T; Anttonen AK; Uusimaa J; Lehesjoki AE; Vieira P
    Neuropediatrics; 2018 Aug; 49(4):256-261. PubMed ID: 29801191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nationwide survey of Alexander disease in Japan and proposed new guidelines for diagnosis.
    Yoshida T; Sasaki M; Yoshida M; Namekawa M; Okamoto Y; Tsujino S; Sasayama H; Mizuta I; Nakagawa M;
    J Neurol; 2011 Nov; 258(11):1998-2008. PubMed ID: 21533827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recessively-Inherited Adult-Onset Alexander Disease Caused by a Homozygous Mutation in the GFAP Gene.
    Fu MH; Chang YY; Lin NH; Yang AW; Chang CC; Liu JS; Peng CH; Wu KLH; Perng MD; Lan MY
    Mov Disord; 2020 Sep; 35(9):1662-1667. PubMed ID: 32374915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Follow-up and genetic study of 43 Chinese children with type Ⅰ Alexander disease].
    Ban TT; Wu Y; Zhang ZB; Zang LL; Wang JM; Jiang YW
    Zhonghua Er Ke Za Zhi; 2017 Jul; 55(7):504-508. PubMed ID: 28728258
    [No Abstract]   [Full Text] [Related]  

  • 7. Unusual presentations and intrafamilial phenotypic variability in infantile onset Alexander disease.
    Tonduti D; Ardissone A; Ceccherini I; Giaccone G; Farina L; Moroni I
    Neurol Sci; 2016 Jun; 37(6):973-7. PubMed ID: 26743065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical aspects and pathology of Alexander disease, and morphological and functional alteration of astrocytes induced by GFAP mutation.
    Yoshida T; Nakagawa M
    Neuropathology; 2012 Aug; 32(4):440-6. PubMed ID: 22118268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggregation-prone GFAP mutation in Alexander disease validated using a zebrafish model.
    Lee SH; Nam TS; Kim KH; Kim JH; Yoon W; Heo SH; Kim MJ; Shin BA; Perng MD; Choy HE; Jo J; Kim MK; Choi SY
    BMC Neurol; 2017 Sep; 17(1):175. PubMed ID: 28882119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I Alexander disease: Update and validation of the clinical evolution-based classification.
    Vaia Y; Mura E; Tonduti D
    Mol Genet Metab; 2023 Mar; 138(3):107540. PubMed ID: 36804850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does genetic anticipation occur in familial Alexander disease?
    Hunt CK; Al Khleifat A; Burchill E; Ederle J; Al-Chalabi A; Sreedharan J
    Neurogenetics; 2021 Jul; 22(3):215-219. PubMed ID: 34046764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alexander disease - astrogliopathy considered as leukodystrophy - experience of an institution.
    Mierzewska H; Mierzewska-Schmidt M; Salomons GS; Dudzińska M; Szczepanik E
    Dev Period Med; 2016; 20(2):110-7. PubMed ID: 27442695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative stabilities of wild-type and mutant glial fibrillary acidic protein in patients with Alexander disease.
    Heaven MR; Wilson L; Barnes S; Brenner M
    J Biol Chem; 2019 Oct; 294(43):15604-15612. PubMed ID: 31484723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alexander disease evolution over time: data from an Italian cohort of pediatric-onset patients.
    Mura E; Nicita F; Masnada S; Battini R; Ticci C; Montomoli M; Berardinelli A; Pantaleoni C; Ardissone A; Foiadelli T; Tartara E; Salsano E; Veggiotti P; Ceccherini I; Moroni I; Bertini E; Tonduti D
    Mol Genet Metab; 2021 Dec; 134(4):353-358. PubMed ID: 34865968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GFAP Mutations in Astrocytes Impair Oligodendrocyte Progenitor Proliferation and Myelination in an hiPSC Model of Alexander Disease.
    Li L; Tian E; Chen X; Chao J; Klein J; Qu Q; Sun G; Sun G; Huang Y; Warden CD; Ye P; Feng L; Li X; Cui Q; Sultan A; Douvaras P; Fossati V; Sanjana NE; Riggs AD; Shi Y
    Cell Stem Cell; 2018 Aug; 23(2):239-251.e6. PubMed ID: 30075130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult-onset Alexander disease among patients of Jewish Syrian descent.
    Anis S; Fay-Karmon T; Lassman S; Shbat F; Lesman-Segev O; Mor N; Barel O; Dominissini D; Chorin O; Pras E; Greenbaum L; Hassin-Baer S
    Neurogenetics; 2023 Oct; 24(4):303-310. PubMed ID: 37658208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GFAP variants leading to infantile Alexander disease: Phenotype and genotype analysis of 135 cases and report of a de novo variant.
    Heshmatzad K; Haghi Panah M; Tavasoli AR; Ashrafi MR; Mahdieh N; Rabbani B
    Clin Neurol Neurosurg; 2021 Aug; 207():106754. PubMed ID: 34146839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards genomic database of Alexander disease to identify variations modifying disease phenotype.
    Yasuda R; Nakano M; Yoshida T; Sato R; Adachi H; Tokuda Y; Mizuta I; Saito K; Matsuura J; Nakagawa M; Tashiro K; Mizuno T
    Sci Rep; 2019 Oct; 9(1):14763. PubMed ID: 31611638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial fibrillary acidic protein is pathologically modified in Alexander disease.
    Lin NH; Jian WS; Snider N; Perng MD
    J Biol Chem; 2024 Jul; 300(7):107402. PubMed ID: 38782207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for GFAP rearrangements in a cohort of Alexander disease and undetermined leukoencephalopathy patients.
    Ferreira MC; Dorboz I; Rodriguez D; Boespflug Tanguy O
    Eur J Med Genet; 2015 Sep; 58(9):466-70. PubMed ID: 26208460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.